Valuation: Burning Rock Biotech Limited

Market Cap 76Cr 11Cr 9.84Cr 9.09Cr 8.4Cr 16Cr 1.08TCr 16Cr 108.43Cr 43Cr 529.37Cr 42Cr 41Cr 1.82TCr P/E 2024
-1.46x
P/E 2025 -27.1x
Enterprise Value 32Cr 4.79Cr 4.19Cr 3.87Cr 3.58Cr 6.74Cr 460.38Cr 6.86Cr 46Cr 18Cr 225.43Cr 18Cr 18Cr 776.22Cr EV / Sales 2024
0.06x
EV / Sales 2025 2x
Free-Float
61.34%
Yield 2024 *
-
Yield 2025 -
1 day-6.66%
1 week-7.40%
Current month+18.88%
1 month+13.58%
3 months-49.97%
6 months-65.11%
Current year-50.62%
1 week 9.95
Extreme 9.95
12.19
1 month 6.79
Extreme 6.79
12.89
Current year 6.79
Extreme 6.79
41.72
1 year 4.47
Extreme 4.4684
41.72
3 years 2.18
Extreme 2.18
41.72
5 years 2.18
Extreme 2.18
286
10 years 2.18
Extreme 2.18
397.5
Manager TitleAgeSince
Corporate Officer/Principal - 01/01/2014
Chief Executive Officer 48 01/01/2014
Director of Finance/CFO - 27/09/2024
Director TitleAgeSince
Director/Board Member 63 01/08/2016
Chairman 48 -
Director/Board Member 55 01/06/2014
Date Insider Type Main position Quantity % Market Cap.
26/06Buy

Chief Executive Officer

24,900 0.0283%
31/03Buy

Chief Executive Officer

3,14,870 0.3584%
18/03
Northern Light Venture Capital Development Ltd.
OtherCompany 1,18,80,245 13.5213%
Change 5-day change 1-year change 3-year change Capi.($)
-6.66%-7.40%+114.90%-53.50% 11Cr
-0.15%-1.38%+21.17%+6.53% 977.29Cr
+0.48%-0.07%+12.92%+1.35% 129.65Cr
+13.74%+15.78% - - 133.83Cr
-0.14%+3.07%+2.33%-12.13% 107.06Cr
+2.57%-3.58%+53.28%+28.71% 62Cr
+5.60%+3.86%-19.36%-58.84% 58Cr
+1.15%+2.45%+109.25%+166.06% 42Cr
+0.85%+2.30%-10.88%-12.75% 41Cr
+5.93%+7.76%-56.46%-81.88% 26Cr
Average +2.34%+3.40%+25.24%-1.83% 158.73Cr
Weighted average by Cap. +1.54%+1.81%+19.74%+5.01%

Financials

2024 2025
Net sales 52Cr 7.62Cr 6.66Cr 6.15Cr 5.68Cr 11Cr 731.54Cr 11Cr 73Cr 29Cr 358.21Cr 29Cr 28Cr 1.23TCr 54Cr 7.97Cr 6.96Cr 6.44Cr 5.95Cr 11Cr 765.22Cr 11Cr 77Cr 30Cr 374.7Cr 30Cr 29Cr 1.29TCr
Net income -35Cr -5.12Cr -4.47Cr -4.13Cr -3.82Cr -7.19Cr -491.59Cr -7.32Cr -49Cr -19Cr -240.71Cr -19Cr -19Cr -828.84Cr -5.53Cr -81.72L -71.41L -66.02L -60.99L -1.15Cr -78Cr -1.17Cr -7.87Cr -3.09Cr -38Cr -3.07Cr -3Cr -132.34Cr
Net Debt -47Cr -6.99Cr -6.11Cr -5.65Cr -5.22Cr -9.83Cr -671.75Cr -10Cr -67Cr -26Cr -328.94Cr -26Cr -26Cr -1.13TCr -44Cr -6.46Cr -5.65Cr -5.22Cr -4.82Cr -9.08Cr -620.71Cr -9.25Cr -62Cr -24Cr -303.94Cr -24Cr -24Cr -1.05TCr
Logo Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Employees
667
Date Price Change Volume
14/26/14 $9.950 -6.66% 3,042
13/26/13 $10.66 -5.66% 23,562
10/26/10 $11.30 -3.42% 25,689
09/26/09 $11.70 -0.43% 25,342
08/26/08 $11.75 +9.35% 39,924